医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | 5,7-dichloro-2-(pyridin-2-yl)pyrazolo[1,5-a]pyrimidine | 1232223-43-6 | C11H6Cl2N4 |
|
—— | cis-2,3-Dimethyl-cyclohexanol | 1502-24-5 | C8H16O |
|
—— | 5-bromo-3-isopropyl-1H-pyrrolo[2,3-b]pyridine | 1256819-54-1 | C10H11BrN2 |
|
—— | 1-(2,4-Dimethylphenyl)-3-phenyl-1H-pyrazole-5(4H)-one | 1003751-09-4 | C17H16N2O |
|
—— | 2-methyl-4-hydroxy-5,6-dichloropyrimidine | 32265-50-2 | C5H4Cl2N2O |
|
—— | L-methoxyproline | 75176-09-9 | C6H11NO3 |
|
—— | 8-nitro-quinoline-4-carboxylic acid | 121689-22-3 | C10H6N2O4 |
|
—— | 2-bromo-4-chloro-3-fluorobenzoic acid | 170108-06-2 | C7H3BrClFO2 |
|
—— | 2,8-dichloro-7-nitro-1,5-naphthyridine | 1366050-48-7 | C8H3Cl2N3O2 |
|
—— | 1-methyl-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine | 1228994-66-8 | C7H11N3 |
|
—— | 2-chloro-5-nitropyrimidine-4,6-diamine | 408352-74-9 | C4H4ClN5O2 |
|
—— | tert-butyl 4-(1H-indazol-3-yl)piperidine-1-carboxylate | 889945-69-1 | C17H23N3O2 |
|
—— | 3-bromo-2-methoxy-9H-carbazole | 890079-77-3 | C13H10BrNO |
|
—— | ethyl imidazo[1,2-a]pyridine-2-carboxylate hydrobromide | 38922-77-9 | BrH*C10H10N2O2 |
|
—— | (6<i>R</i>)-7<i>t</i>-(2-bromo-acetylamino)-3-methyl-8-oxo-(6<i>r</i><i>H</i>)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid | 58197-02-7 | C10H11BrN2O4S |
|
—— | longifolan-15-ol | 469-27-2 | C15H26O |
|
—— | estra-1,3,5(10)-triene-3,17β-diol 17β-hemisuccinate | 7698-93-3 | C22H28O5 |
|
—— | pyrazolo[1,5-a]pyridine-6-carboxylic acid | 474432-61-6 | C8H6N2O2 |
|
—— | 3-(aminomethyl)pyridine 1-oxide hydrochloride | 106940-10-7 | C6H8N2O*ClH |
|
—— | syn-tert-butyl ((5S,6R)-6-methyl-2-oxo-5-phenylpiperidin-3-yl)carbamate | 1375541-78-8 | C17H24N2O3 |
|
—— | N-Methyldichloropane hydrochloride | 150653-91-1 | C16H20Cl3NO2 |
|
—— | D-Glucitol, bis-O-[(4-methylphenyl)methylene]- | 54686-97-4 | C22H26O6 |
|
—— | sodium salt of sulfanilic acid 2-pyridylamide | 127-57-1 | C11H10N3O2S*Na |
|
—— | tert-butyl (4aR,7aR)-octahydro-1H-pyrrolo[3,4-b]pyridine-1-carboxylate | 159877-36-8 | C12H22N2O2 |
|
—— | 5-bromo-4-chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine | 717900-59-9 | C11H11BrClN3 |
|
—— | 3-oxo-1-phenyl-2,7,10,13-tetraoxa-4-azahexadecan-16-oic acid | 1310327-18-4 | C17H25NO7 |
|
—— | 5-((+)-biotinamido)pentylamine trifluoroacetic acid | 288259-39-2 | C2HF3O2*C15H28N4O2S |
|
—— | (15S)-Prostaglandin A2 | 13345-50-1 | C20H30O4 |
|
—— | (1R,4S,5'S,6R,6'S,8R,10E,12S,13S,14E,16E,20R,21E,24S)-6'-cyclohexyl-24-hydroxy-21-hydroxyimino-12-[(4S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one | 220119-17-5 | C43H63NO11 |
|
—— | methyl (4-amino-3,5-dichloro-6-fluoro-2-pyridinyloxy)acetate | 69184-17-4 | C8H7Cl2FN2O3 |
|
—— | 4,4''-di(4-pyridyl)-4',5'-bis[4-(4-pyridyl)-phenyl]-1,1':2',1''-terphenyl | 591215-20-2 | C50H34N4 |
|
—— | tert-butyl (S)-2-ethynylmorpholine-4-carboxylate | 1621165-19-2 | C11H17NO3 |
|
—— | Imino-bis-carbimidsaeuremethylester | 25649-35-8 | C4H9N3O2 |
|
—— | 2-Methylaminomethyl-cyclohexanol | 87974-29-6 | C8H17NO |
|
—— | (1R,4S,5'S,6R,6'S,8R,10E,12S,13S,14E,16E,20R,21E,24S)-6'-cyclohexyl-24-hydroxy-21-hydroxyimino-12-[(2R,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one | 165108-07-6 | C43H63NO11 |
|
—— | Ionomycincalciumsalt | 56092-82-1 | C41H70CaO9 |
|
—— | 4-formyl-3-(hydroxymethyl)benzoic acid ethylester | 82304-99-2 | C11H12O4 |
|
—— | 1-(3-chlorophenyl)-5-methyl-1H-pyrazole-3-carboxylic acid | 1175972-08-3 | C11H9ClN2O2 |
|
—— | sudexanox | 58761-87-8 | C4H11NO3*C21H23NO5S |
|
—— | 1,2,3,4-Tetrahydroisoquinolin-2-ium-6,7-diol | 52768-23-7 | C9H12NO2+ |
|
—— | 5-(methoxycarbonyl)-1H-pyrrole-3-carboxylic acid | 67858-48-4 | C7H7NO4 |
|
—— | benzyl N-[6-oxo-6-[[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino]hexyl]carbamate | 38822-58-1 | C20H30N2O8 |
|
—— | Catharanthin | 467-77-6 | C21H26N2O2 |
|
—— | (1R,5'S,6R,6'S,8R,10E,12S,13S,14E,16E,20R,21Z,24S)-6'-cyclohexyl-24-hydroxy-21-hydroxyimino-12-[(2R,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one | 165108-07-6 | C43H63NO11 |
|
—— | Selgantolimod | 2004677-13-6 | C14H20FN5O |
|
—— | Disodium 4-hydroxy-6-(phenylamino)-3-((4-sulphonatophenyl)azo)naphthalene-2-sulphonate | 6222-56-6 | C22H15N3Na2O7S2 |
|
—— | Disodium 2'-(4-((1-hydroxy-7-(phenylamino)-3-sulphonato-2-naphthyl)azo)phenyl)-6-methyl(2,6'-bibenzothiazole)-7-sulphonate | 6222-60-2 | C37H23N5Na2O7S4 |
|
—— | 24,25 Dihydroxyvitamin D3 | 55721-11-4 | C27H44O3 |
|
—— | 2-[2-[2-[Bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]ethyl-(carboxymethyl)amino]-3-phenylmethoxypropanoic acid;gadolinium | 113662-23-0 | C22H31GdN3O11 |
|
—— | (2R)-2-{[(5Sa)-5-{3-chloro-2-methyl-4-[2-(4-methylpiperazin-1-yl)ethoxy]phenyl}-6-(5-fluorofuran-2-yl)thieno[2,3-d]pyrimidin-4-yl]oxy}-3-(2-{[1-(2,2,2-trifluoroethyl)-1H-pyrazol-5-yl]methoxy}phenyl)propanoic acid | 1799633-27-4 | C39H37ClF4N6O6S |
|